These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 10968905

  • 21. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K, Yasumuro Y, Taki M, Suzuki Y, Akatu S, Tajima C, Ichikawa Y.
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [Abstract] [Full Text] [Related]

  • 23. Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'.
    Exner T, Papadopoulos G, Koutts J.
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):259-66. PubMed ID: 2129412
    [Abstract] [Full Text] [Related]

  • 24. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B, Chantarangkul V, Rojnuckarin P, Juntiang J.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [Abstract] [Full Text] [Related]

  • 25. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L, Whitis JG, Embry MB, Hollensead SC.
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [Abstract] [Full Text] [Related]

  • 26. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time.
    Moore GW, Savidge GF, Smith MP.
    Blood Coagul Fibrinolysis; 2000 Dec; 11(8):767-74. PubMed ID: 11132656
    [Abstract] [Full Text] [Related]

  • 27. Lupus anticoagulant testing: performance and practices by north american clinical laboratories.
    Dembitzer FR, Ledford Kraemer MR, Meijer P, Peerschke EI.
    Am J Clin Pathol; 2010 Nov; 134(5):764-73. PubMed ID: 20959659
    [Abstract] [Full Text] [Related]

  • 28. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T.
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [Abstract] [Full Text] [Related]

  • 29. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
    Galli M, Finazzi G, Norbis F, Marziali S, Marchioli R, Barbui T.
    Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
    [Abstract] [Full Text] [Related]

  • 30. Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer.
    Shirts BH, Rodgers GM, Smock KJ.
    Thromb Res; 2012 Sep; 130(3):e134-8. PubMed ID: 22542363
    [Abstract] [Full Text] [Related]

  • 31. Frequent false-positive results of lupus anticoagulant tests in plasmas of patients receiving the new oral anticoagulants and enoxaparin.
    Martinuzzo ME, Barrera LH, D 'adamo MA, Otaso JC, Gimenez MI, Oyhamburu J.
    Int J Lab Hematol; 2014 Apr; 36(2):144-50. PubMed ID: 24034808
    [Abstract] [Full Text] [Related]

  • 32. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
    McGlasson DL, Fritsma GA.
    Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
    [Abstract] [Full Text] [Related]

  • 33. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW, Henley A, Greenwood CK, Rangarajan S.
    Thromb Res; 2008 Apr; 121(4):477-84. PubMed ID: 17602725
    [Abstract] [Full Text] [Related]

  • 34. The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant.
    Gardiner C, MacKie IJ, Malia RG, Jones DW, Winter M, Leeming D, Taberner DA, Machin SJ, Greaves M.
    Br J Haematol; 2000 Dec; 111(4):1230-5. PubMed ID: 11167766
    [Abstract] [Full Text] [Related]

  • 35. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C.
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [Abstract] [Full Text] [Related]

  • 36. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR, Falcón CR, Carreras LO.
    Haemostasis; 1990 Mar; 20(4):208-14. PubMed ID: 2122955
    [Abstract] [Full Text] [Related]

  • 37. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F, Lang M, Belik S, Jilma-Stohlawetz P, Schmetterer KG, Haslacher H, Perkmann T, Quehenberger P.
    Thromb Haemost; 2016 Aug 01; 116(2):235-40. PubMed ID: 27075441
    [Abstract] [Full Text] [Related]

  • 38. Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional review.
    Jacquot C, Wool GD, Kogan SC.
    Int J Lab Hematol; 2019 Feb 01; 41(1):80-86. PubMed ID: 30194751
    [Abstract] [Full Text] [Related]

  • 39. Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT).
    Pengo V, Bison E, Banzato A, Zoppellaro G, Jose SP, Denas G.
    Methods Mol Biol; 2017 Feb 01; 1646():169-176. PubMed ID: 28804828
    [Abstract] [Full Text] [Related]

  • 40. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test].
    Sato K, Kagami K, Asai M, Nakashima N, Takamatsu J.
    Rinsho Byori; 1995 Mar 01; 43(3):263-8. PubMed ID: 7745832
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.